Histogen : Pipeline Focus on Pan-Caspase and Caspase Selecti

Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases


SAN DIEGO, April 3, 2023 - Histogen Inc. , a clinical-stage therapeutics... | April 3, 2023

Related Keywords

United States , Johns Hopkins , World Health Organization , Johns Hopkins University , Histogen Inc , Exchange Commission , Pipeline Focus , Caspase Selective Inhibitors , Inflammatory Diseases , Private Securities Litigation Reform Act , Histogen Inc Stock Exchange , News , Information , Press Release , Pipeline , Focus , N , End , Raspase , Elective , Inhibitors , Or , Nfectious , Inflammatory , Han , Pril , 023 , Istogen Hsto Us43358y2028 ,